Demant AS Revenue vs. Book Value Per Share

DEMANT Stock  DKK 311.00  2.80  0.89%   
Based on Demant AS's profitability indicators, Demant AS may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in May. Profitability indicators assess Demant AS's ability to earn profits and add value for shareholders.
For Demant AS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Demant AS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Demant AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Demant AS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Demant AS over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Demant AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Demant AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Demant AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Demant AS Book Value Per Share vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Demant AS's current stock value. Our valuation model uses many indicators to compare Demant AS value to that of its competitors to determine the firm's financial worth.
Demant AS is rated as one of the top companies in revenue category among related companies. It is one of the top stocks in book value per share category among related companies . The ratio of Revenue to Book Value Per Share for Demant AS is about  513,659,350 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Demant AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Demant AS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Demant AS's earnings, one of the primary drivers of an investment's value.

Demant Revenue vs. Competition

Demant AS is rated as one of the top companies in revenue category among related companies. Market size based on revenue of Medical Instruments & Supplies industry is currently estimated at about 278.5 Billion. Demant AS holds roughly 19.7 Billion in revenue claiming about 7% of all equities under Medical Instruments & Supplies industry.

Demant Book Value Per Share vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Demant AS

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
19.7 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Demant AS

Book Value per Share

 = 

Common Equity

Average Shares

 = 
38.36 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Demant Book Value Per Share Comparison

Demant AS is currently under evaluation in book value per share category among related companies.

Demant AS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Demant AS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Demant AS will eventually generate negative long term returns. The profitability progress is the general direction of Demant AS's change in net profit over the period of time. It can combine multiple indicators of Demant AS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Demant AS, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant AS operates under Medical Instruments Supplies classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 14614 people.

Demant Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Demant AS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Demant AS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Demant AS's important profitability drivers and their relationship over time.

Use Demant AS in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Demant AS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Demant AS will appreciate offsetting losses from the drop in the long position's value.

Demant AS Pair Trading

Demant AS Pair Trading Analysis

The ability to find closely correlated positions to Demant AS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Demant AS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Demant AS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Demant AS to buy it.
The correlation of Demant AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Demant AS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Demant AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Demant AS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Demant AS position

In addition to having Demant AS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cancer Fighters Thematic Idea Now

Cancer Fighters
Cancer Fighters Theme
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 59 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Demant Stock analysis

When running Demant AS's price analysis, check to measure Demant AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Demant AS is operating at the current time. Most of Demant AS's value examination focuses on studying past and present price action to predict the probability of Demant AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Demant AS's price. Additionally, you may evaluate how the addition of Demant AS to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
To fully project Demant AS's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Demant AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Demant AS's income statement, its balance sheet, and the statement of cash flows.
Potential Demant AS investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Demant AS investors may work on each financial statement separately, they are all related. The changes in Demant AS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Demant AS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.